{"schema_version":"secwatch.filing_event.v1","accession":"0001185185-22-001335","form_type":"8-K","ticker":"STEX","cik":"0001530766","company_name":"Streamex Corp.","filed_at":"2022-11-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.040897+00:00","generated_at":"2026-06-21T15:00:22.723966+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"BioSig raises ~$1.45M in equity at $0.41/share; warrant repricing generates additional $218K","bullets":["Sold 3,541,469 shares at $0.41 each to accredited investors for aggregate proceeds of $1,452,000.","Reduced March Warrants exercise price from $1.40 to $0.25 for a limited window; 510,000 shares issued for $127,500.","Total proceeds from offering and warrant exercises combined are $1,670,250.","Warrant pricing reduction applied only through November 10, 2022; total March Warrants exercised to date: 873,000 shares."],"urls":{"canonical":"https://secwatch.observer/filing/0001185185-22-001335","json":"https://secwatch.observer/filing/0001185185-22-001335.json","markdown":"https://secwatch.observer/filing/0001185185-22-001335.md","text":"https://secwatch.observer/filing/0001185185-22-001335.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1530766/000118518522001335/0001185185-22-001335-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1530766/000118518522001335/biosig20221121_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T15:00:22.723966+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3e23631fe451279e12c6d629c5e23cc23602af59","claim":"Streamex Corp. entered into Securities Purchase Agreement with certain accredited investors valued at $1,452,000 (effective 2022-11-18).","evidence_excerpt":"On November 18, 2022, BioSig Technologies, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain accredited investors (the “Investors”), pursuant to which the Company sold to the Investors an aggregate of 3,541,469 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”) at a purchase price of $0.41 per share, in exchange for aggregate consideration of $1,452,000.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518522001335/0001185185-22-001335-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain accredited investors"},{"label":"Value","value":"$1,452,000"},{"label":"Effective","value":"2022-11-18"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}